The global growth hormone deficiency (GHD) therapy market is experiencing substantial growth, driven by the increasing prevalence of GHD, advancements in therapeutic technologies, and rising demand for personalized treatments. Favorable reimbursement policies and expanding awareness also contribute to the market’s positive outlook.
In 2023, the market size was valued at $1.17 billion...
Dutch 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek